Avacopan
Avacopan is a complement C5a receptor antagonist used for treating ANCA-associated vasculitis.
Detailed technical, regulatory, and supply information is available for commercial evaluation.
Technical Overview
Avacopan – CAS 1346623-17-3
CAS Number
1346623-17-3
Category
Associated Vasculitis
Therapeutic Class
Complement inhibitor
Description
Avacopan is a complement C5a receptor antagonist used for treating ANCA-associated vasculitis.
Applications
- ANCA-associated vasculitis
- Granulomatosis with polyangiitis
Handling & Supply Details
Packaging
Standard export packaging in double-lined HDPE drums or fiber drums with inner poly liners; custom pack sizes available on request.
Product Inquiry
Disclaimer
Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.